Abstract:Congenital heart disease accounts for a third of all congenital defects. The role of protein kinase D1 in cardiogenesis and CHD was studied using a transgenic mouse model (Prkd1em1) carrying deletion of exon 2 (em1), causing loss of function. Morphological 3D analysis by high‐resolution episcopic microscopy has shown a range of CHDs occur in the Prkd1em1 embryonic day E15.5 and the postnatal day (P) 6/7 hearts. Ao, aorta; AS; atrial septum; LA, left atrium; LV, left ventricle; PT, pulmonary trunk; RA, right atrium; RV, right ventricle; VS, ventricular septum. Congenital heart disease (CHD) is the most common congenital anomaly, with an overall incidence of approximately 1% in the United Kingdom. Exome sequencing in large CHD cohorts has been performed to provide insights into the genetic aetiology of CHD. This includes a study of 1891 probands by our group in collaboration with others, which identified three novel genes—CDK13, PRKD1, and CHD4, in patients with syndromic CHD. PRKD1 encodes a serine/threonine protein kinase, which is important in a variety of fundamental cellular functions. Individuals with a heterozygous mutation in PRKD1 may have facial dysmorphism, ectodermal dysplasia and may have CHDs such as pulmonary stenosis, atrioventricular septal defects, coarctation of the aorta and bicuspid aortic valve. To obtain a greater appreciation for the role that this essential protein kinase plays in cardiogenesis and CHD, we have analysed a Prkd1 transgenic mouse model (Prkd1em1) carrying deletion of exon 2, causing loss of function. High‐resolution episcopic microscopy affords detailed morphological 3D analysis of the developing heart and provides evidence for an essential role of Prkd1 in both normal cardiac development and CHD. We show that homozygous deletion of Prkd1 is associated with complex forms of CHD such as atrioventricular septal defects, and bicuspid aortic and pulmonary valves, and is lethal. Even in heterozygotes, cardiac differences occur. However, given that 97% of Prkd1 heterozygous mice display normal heart development, it is likely that one normal allele is sufficient, with the defects seen most likely to represent sporadic events. Moreover, mRNA and protein expression levels were investigated by RT‐qPCR and western immunoblotting, respectively. A significant reduction in Prkd1 mRNA levels was seen in homozygotes, but not heterozygotes, compared to WT littermates. While a trend towards lower PRKD1 protein expression was seen in the heterozygotes, the difference was only significant in the homozygotes. There was no compensation by the related Prkd2 and Prkd3 at transcript level, as evidenced by RT‐qPCR. Overall, we demonstrate a vital role of Prkd1 in heart development and the aetiology of CHD.

From phenotype to mechanism: Prenatal spectrum of NKAP mutation‐related disorder and its pathogenesis inducing congenital heart disease

NEXN Inhibits GATA4 and Leads to Atrial Septal Defects in Mice and Humans

Integrated Facial Analysis and Targeted Sequencing Identifies a Novel KDM6A Pathogenic Variant Resulting in Kabuki Syndrome

Autosomal Dominant Sleep-Related Hypermotor Epilepsy Associated with a Novel Mutation of KCNT1.

Prevalence and Spectrum of Nkx2.6 Mutations in Patients with Congenital Heart Disease.

A Novel Nkx2.6 Mutation Associated with Congenital Ventricular Septal Defect

A Novel Splicing Mutation C.335–1 G > A in the Cardiac Transcription Factor NKX2-5 Leads to Familial Atrial Septal Defect Through Mir-19 and PYK2

An X-linked PLXNB3 Mutation Identified in Patients with Congenital Heart Disease with Neurodevelopmental Disabilities.

Mutation Screening of NKx 2.5 Gene and its Relationship to Simple Congenital Heart Disease in 81 Patients

A Novel Nkx2-5 Loss-Of-Function Mutation Predisposes to Familial Dilated Cardiomyopathy and Arrhythmias

The Expression Profile Analysis of NKX2-5 Knock-out Embryonic Mice to Explore the Pathogenesis of Congenital Heart Disease.

Next-generation Sequencing Identified Novel Desmoplakin Frame-Shift Variant in Patients with Arrhythmogenic Cardiomyopathy

Nkx2-6 Mutation Predisposes To Familial Atrial Fibrillation

Investigation Of Somatic Nkx2-5 Mutations In Chinese Children With Congenital Heart Disease

Genetic Analysis of Rare Coding Mutations of CELSR1-3 in Congenital Heart and Neural Tube Defects in Chinese People.

Identification of Candidate Genes for Congenital Heart Defects on Proximal Chromosome 8P

Prevalence and Spectrum of NKX2.5 Mutations in Patients with Congenital Atrial Septal Defect and Atrioventricular Block.

ENU-based dominant genetic screen identifies contractile and neuronal gene mutations in congenital heart disease

Mitotic Block and Epigenetic Repression Underlie Neurodevelopmental Defects and Neurobehavioral Deficits in Congenital Heart Disease

Discovery and Functional Investigation of BMP4 As a New Causative Gene for Human Congenital Heart Disease

Effect of deletion of the protein kinase PRKD1 on development of the mouse embryonic heart